CBLB and non-small cell lung carcinoma: Furthermore, we demonstrated that DUXAP9‐206 induced NSCLC cell proliferation and metastasis by directly interacting with Cbl‐b, an E3 ubiquitin ligase and reducing the degradation of EGFR, thus activating the EGFR signaling pathway.